Roche reports interim results for phase-III Skycraper-01 study in PD-L1-high metastatic non-small cell lung cancer Read more
CEPI partners with consortium of Bharat Biotech, University of Sydney and ExcellGene to develop ‘variant-proof’ COVID-19 vaccine Read more